Abstract:
PURPOSE: A method for forming a fine fluorescent image by using protected hydroxy group-containing anthraquinone derivatives or naphthacenequinone derivatives is provided. Thereby the obtained protected hydroxy group-containing compound can be applied to recording material and censor material because it can easily form a fine fluorescent image of micrometer units under the condition of a chemically amplified fine image forming process. CONSTITUTION: This method comprises the steps of: preparing a transparent solution by dissolving protected hydroxy group-containing anthraquinone derivatives of formula 1 or naphthacenequinone derivatives of formula 2 and a soluble polymer in an organic solvent; forming a thin film by coating the solution on a substrate; prebaking the thin film coated substrate; and removing a hydroxy protecting group of the anthraquinone derivatives or naphthacenequinone derivatives by treating under the condition of a chemically amplified fine image forming process.
Abstract:
일산화질소를 조절 방출할 수 있는 고분자 전달체를 개시한다. 본 발명의 일산화질소 전달체는 유기 고분자의 주사슬과 이 주사슬에 공유 결합으로 연결되어 있으며, 디아제늄디올레이트 작용기를 갖추고 있는 부사슬을 포함하는 중합체 분자이다. 본 발명의 일산화질소 조절 방출용 전달체는 상온에서 액체 등의 유동성이 있는 유체 상태로 존재하다가 생체내 pH 조건에서 임계 온도 이상으로 승온시 졸에서 겔로 상전이를 일으키는데, 이 상 전이의 임계 온도는 25~35℃의 범위에 있고, 상기 겔은 화학 가교 형성이 없이 이루어지는 수화겔(hydrogel)이다. 아울러 본 발명에서는 이러한 일산화질소 조절 방출용 전달체로 표면을 피복한 인공 체내 삽입물을 개시한다.
Abstract:
PURPOSE: A multiple coating stent for controlling the medicine emission, and a manufacturing method thereof are provided to form three coating layers of different drugs by emitting ultrasonic waves. CONSTITUTION: A manufacturing method of a multiple coating stent for controlling the medicine emission comprises the following steps: ultrasonic wave-spraying a mixed solution of a first drug and a biodegradable polymer on the surface of a stent for forming a first coating layer; ultrasonic wave-spraying a biodegradable polymer solution on the upper side of the first coating layer for forming a second coating layer; ultrasonic wave-spraying a second mixed solution of a second drug and the biodegradable polymer on the upper side of the second coating layer for forming a third coating layer; and forming a fourth coating layer on the third coating layer using a biodegradable polymer. The first or second drug is selected from polyvinyl alcohol, saponin, carboxymethyl cellulose, or mono grylceride.